Tight Junction Protein Signaling and Cancer Biology
Cells · 2023
DOI: 10.3390/cells12020243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Zeina Nehme und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France. Hauptthemen laut MEDLINE: Tight Junction Proteins, Neoplasms. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCI NIH HHS, European Research Council.
Abstract (Originalsprache)
Tight junctions (TJs) are intercellular protein complexes that preserve tissue homeostasis and integrity through the control of paracellular permeability and cell polarity. Recent findings have revealed the functional role of TJ proteins outside TJs and beyond their classical cellular functions as selective gatekeepers. This is illustrated by the dysregulation in TJ protein expression levels in response to external and intracellular stimuli, notably during tumorigenesis. A large body of knowledge has uncovered the well-established functional role of TJ proteins in cancer pathogenesis. Mechanistically, TJ proteins act as bidirectional signaling hubs that connect the extracellular compartment to the intracellular compartment. By modulating key signaling pathways, TJ proteins are crucial players in the regulation of cell proliferation, migration, and differentiation, all of which being essential cancer hallmarks crucial for tumor growth and metastasis. TJ proteins also promote the acquisition of stem cell phenotypes in cancer cells. These findings highlight their contribution to carcinogenesis and therapeutic resistance. Moreover, recent preclinical and clinical studies have used TJ proteins as therapeutic targets or prognostic markers. This review summarizes the functional role of TJ proteins in cancer biology and their impact for novel strategies to prevent and treat cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France.
- Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, 79098 Freiburg, Germany.
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, 68198 NE, USA.
- Buffet Cancer Center, University of Nebraska Medical Center, Omaha, 68105 NE, USA.
- VA Nebraska-Western Iowa Health Care System, Omaha, 68105-1850 NE, USA.
- Institut Hospitalo-Universitaire (IHU), Pôle Hépato-Digestif, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
ORCID-Profile: Zeina Nehme, Thomas F Baumert
Förderung
- BLRD VA
- NCI NIH HHS
- European Research Council
- SATT Conectus, University of Strasbourg (CANCLAU)
- French National Research Agency
- Berta-Ottenstein Programme, University Freiburg
- IdEx Unistra
- SFRI-STRAT’US project
Zitieren
APA
Nehme, Z., Roehlen, N., Dhawan, P., & Baumert, T. F. (2023). Tight Junction Protein Signaling and Cancer Biology. Cells. https://doi.org/10.3390/cells12020243
Vancouver
Nehme Z, Roehlen N, Dhawan P, Baumert TF. Tight Junction Protein Signaling and Cancer Biology. Cells. 2023. doi:10.3390/cells12020243
BibTeX
@article{Nehme2023,
author = {Nehme, Zeina and Roehlen, Natascha and Dhawan, Punita and Baumert, Thomas F},
title = {Tight Junction Protein Signaling and Cancer Biology},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12020243}
}
EUVIMED